Literature DB >> 14723111

Medications for dry eye syndrome: a drug-therapy review.

Henry D Perry1, Eric D Donnenfeld.   

Abstract

Early interventions were palliative, attempting to replace water lost from the tear film. Today, therapy is directed at the underlying inflammation, a recognized component of dry eye syndrome, and at the resulting progressive changes to the ocular surface. This approach offers promise of lasting relief to patients with moderate to severe symptoms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14723111

Source DB:  PubMed          Journal:  Manag Care        ISSN: 1062-3388


  2 in total

1.  Assessing the effectiveness of OTC Advertising on artificial tear drops from an experiential marketing perspective.

Authors:  Consuela-Mădălina Gheorghe; Victor Lorin Purcărea; Iuliana Raluca Gheorghe
Journal:  Rom J Ophthalmol       Date:  2019 Jul-Sep

Review 2.  Over the counter (OTC) artificial tear drops for dry eye syndrome.

Authors:  Andrew D Pucker; Sueko M Ng; Jason J Nichols
Journal:  Cochrane Database Syst Rev       Date:  2016-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.